Novel effects other than antisecretory action and off-label use of proton pump inhibitors

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.1, 2005-01, pp. : 59-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Off-label use of medicines in children: can available evidence avoid useless paediatric trials?: The case of proton pump inhibitors for the treatment of gastroesophageal reflux disease

By Tafuri Giovanni Trotta Francesco Leufkens Hubert Martini Nello Sagliocca Luciano Traversa Giuseppe

European Journal of Clinical Pharmacology, Vol. 65, Iss. 2, 2009-02 ,pp. : 209-216

Springer Publishing Company

Access to resources Recommend Favorite

Antibiotic Use in Children - Off-Label Use

Current Drug Targets, Vol. 13, Iss. 7, 2012-06 ,pp. : 885-892

Bentham Science Publishers

Access to resources Recommend Favorite

ADRs with off-label use of quinine continue

Reactions Weekly, Vol. 1, Iss. 1259, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Off-label use of bevacizumab linked to eye inflammation

Reactions Weekly, Vol. 1, Iss. 1234, 2009-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Rising off-label use of antipsychotics a concern in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 621, 2011-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite